Rapid Maize/Tapioca Starch IP/BP is available as per India, British and United States pharmacopoeia standards.

Maize Starch (IP/BP) is purposefully crafted for the pharmaceutical sector, primarily serving as a binder and filler for tablets and capsules. Its versatility extends to applications in coating and dusting media, including sugar and enteric coating. In dry granulation techniques, particularly beneficial for hygroscopic active ingredients, Maize Starch (IP/BP/USP) excels as an efficient dry-binder, addressing challenges in drying post-wet binding.

What sets this starch apart is its specialized treatment, meticulously controlling the bio-load, focusing on Total Viable Counts (TVC), Yeast Mould, and Gram-negative bacteria. This control proves pivotal, especially in formulations involving antibiotics and vitamins, where bacterial contamination can compromise shelf life. By incorporating Maize Starch with a regulated bio-load, pharmaceutical manufacturers enhance the quality and longevity of their products, ensuring integrity throughout the supply chain.